10.06.26 -- Early Drug Effects Missed, Trial Workloads Underestimated

The EU Clinical Trials Regulation is now redefining how clinical trials are conducted across Europe. From harmonised submissions and greater transparency to new operational demands, the CTR has wide-ranging implications for sponsors. This article explores six key considerations that can help drug developers prepare for regulatory success and optimise their early clinical development strategy. Read the article.

AI is transforming clinical development, but what happens when usage costs spike? Jon Newton explains how to govern it before the bill lands.